Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCQS Natural Resources Growth & Income Regulatory News (CYN)

Share Price Information for CQS Natural Resources Growth & Income (CYN)

Share Price is delayed by 15 minutes
Get Live Data
370.00    -4.00 (-1.06%)
Bid:
370.00
Ask:
377.00
Spread: 7.00 (1.892%)
Market Cap: £134.36m
CYN Live PriceLast checked at - London Stock Exchange

Intraday CQS Natural Resources Growth & Income Share Chart

Flash note from QuotedData

13 Jan 2025 11:34

RNS Number : 1058T
CQS Natural Resources Grwth&Inc PLC
13 January 2025
 

CQS Natural Resources Growth and Income - Flash note from QuotedData

13th January 2025

Protect your investment - get out and vote

On 18 December 2024, CQS Natural Resources Growth and Income (CYN) received a requisition notice from a nominee of Saba Capital Management LP (Saba) requiring it to convene a general meeting for shareholders to consider resolutions proposed by Saba to remove the existing completely-independent board of non-executive directors and replace it with two directors of Saba's choosing.

On 7 January 2025, CYN's board issued a comprehensive rebuttal of Saba's proposals when it published a circular (a formal document sent to shareholders) in relation to the requisitioned meeting - it describes Saba's proposals as "self-interested and misleading." The board's position is very clear - it is unanimous in recommending shareholders vote against Saba's resolutions.

From the outset, we have cautioned shareholders against giving full control of the trust to one dominant shareholder that would be free to act entirely in its own interests. Saba has made clear its intention to get itself appointed as manager and merge the seven targets into one large vehicle with a mandate to attack other investment companies. The FCA's (Financial Conduct Authority) Listing Rules make it clear that the board of directors of an investment company must be able to act independently of any investment manager. We are not comfortable that Saba's proposals meet this requirement.

With so much at stake, we thought we should take a deeper look at Saba's proposals and CYN's board's response to these, to see what the merits are. Our conclusion is that Saba's plans for CYN are so poor for all shareholders other than itself that its proposals deserve to be voted down comprehensively. We urge all shareholders: protect your investment and get out and vote.

Full Research:

https://quoteddata.com/research/cqs-natural-resources-growth-and-income-protect-your-investment-get-out-and-vote-qd/

This research is also available free on our website www.quoteddata.com where you will also find news, performance data and factsheets on every London listed Investment Company. QuotedData writes and distributes research on a number of quoted companies, facilitates meetings between those companies and existing and potential investors and assists in raising additional capital where required.

NB: Marten & Co was paid to produce this note CQS Natural Resources Growth and Income Plc, and it is for information purposes only. It is not intended to encourage the reader to deal in the security or securities mentioned in this report. Please read the important information at the back of this note. QuotedData is a trading name of Marten & Co Limited which is authorised and regulated by the Financial Conduct Authority. Marten & Co is not permitted to provide investment advice to individual investors categorised as Retail Clients under the rules of the Financial Conduct Authority.

QUOTEDDATA50 Gresham Street | London EC2V 7AYTel: +44 (0) 20 3691 9430

www.quoteddata.com | research@quoteddata.com | www.martenandco.com

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAUOOARVAUAAAR
Date   Source Headline
24th Sep 202412:23 pmRNSNet Asset Value(s)
23rd Sep 20246:24 pmRNSMonthly Fact Sheet as at 30 August 2024
23rd Sep 20241:12 pmRNSNet Asset Value(s)
23rd Sep 20249:25 amRNSCompliance with Market Abuse Regulation
20th Sep 20245:44 pmRNSTransaction in Own Shares
20th Sep 20241:43 pmRNSNet Asset Value(s)
19th Sep 20245:30 pmRNSTransaction in Own Shares
19th Sep 20244:20 pmRNSHolding(s) in Company
19th Sep 202412:24 pmRNSNet Asset Value(s)
18th Sep 20245:31 pmRNSTransaction in Own Shares
18th Sep 20242:12 pmRNSHolding(s) in Company
18th Sep 20241:19 pmRNSNet Asset Value(s)
17th Sep 20245:33 pmRNSTransaction in Own Shares
17th Sep 20241:08 pmRNSNet Asset Value(s)
16th Sep 20245:11 pmRNSTransaction in Own Shares
16th Sep 202412:46 pmRNSNet Asset Value(s)
13th Sep 20241:00 pmRNSNet Asset Value(s)
12th Sep 20245:20 pmRNSTransaction in Own Shares
12th Sep 202412:12 pmRNSNet Asset Value(s)
11th Sep 20242:43 pmRNSNet Asset Value(s)
10th Sep 20245:26 pmRNSTransaction in Own Shares
10th Sep 20243:40 pmRNSNet Asset Value(s)
9th Sep 20245:17 pmRNSTransaction in Own Shares
9th Sep 202412:36 pmRNSNet Asset Value(s)
6th Sep 20242:49 pmRNSNet Asset Value(s)
6th Sep 202410:06 amRNSMonthly Fact Sheet as at 31 July 2024
5th Sep 20245:18 pmRNSTransaction in Own Shares
5th Sep 20242:46 pmRNSNet Asset Value(s)
4th Sep 20245:09 pmRNSTransaction in Own Shares
4th Sep 20244:21 pmRNSNet Asset Value(s)
3rd Sep 20245:21 pmRNSTransaction in Own Shares
3rd Sep 20243:05 pmRNSNet Asset Value(s)
2nd Sep 20245:17 pmRNSTransaction in Own Shares
2nd Sep 20245:09 pmRNSNet Asset Value(s)
2nd Sep 20249:45 amRNSTotal Voting Rights
30th Aug 20245:17 pmRNSTransaction in Own Shares
30th Aug 20242:54 pmRNSNet Asset Value(s)
29th Aug 20245:30 pmRNSTransaction in Own Shares
29th Aug 20243:08 pmRNSNet Asset Value(s)
28th Aug 20245:24 pmRNSTransaction in Own Shares
28th Aug 202412:44 pmRNSNet Asset Value(s)
27th Aug 20245:47 pmRNSTransaction in Own Shares
27th Aug 20241:31 pmRNSNet Asset Value(s)
23rd Aug 20245:31 pmRNSTransaction in Own Shares
23rd Aug 20241:40 pmRNSNet Asset Value(s)
22nd Aug 20245:08 pmRNSTransaction in Own Shares
22nd Aug 20241:04 pmRNSNet Asset Value(s)
21st Aug 202412:27 pmRNSNet Asset Value(s)
20th Aug 20241:19 pmRNSNet Asset Value(s)
19th Aug 202412:07 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.